Jamie Robinson, MD
Transplant Surgery · Bethesda, MDNPI 1528354115
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,024 of the $6,177 with a category attached, or 65.1%. 10 manufacturers reported payments, led by Boston Scientific at 43.3% of the total. Reporting peaked in 2024 at $3,790 and has fallen 53.4% since, to $1,767 in 2025.
Across 42 payments — averaging $147.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$3K
- Intuitive Surgical$2K
- Dilon Technologies, Inc.$490
- Sanofi-aventis U.S. LLC$259
- AstraZeneca$106
- Veloxis Pharmaceuticals, Inc.$53
- plus $116 from 4 others
What the payments were for
- Travel & lodging$2,15335%
- Food & beverage$4,02465%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 13 | $2,672 |
| Intuitive Surgical | 14 | $2,482 |
| Dilon Technologies, Inc. | 5 | $490 |
| Sanofi-aventis U.S. LLC | 2 | $259 |
| AstraZeneca | 1 | $106 |
| Veloxis Pharmaceuticals, Inc. | 2 | $53 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $47 |
| Integra Lifesciences Corporation | 1 | $31 |
| Merck | 1 | $19 |
| Novo Nordisk | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few transplant surgery providers in Marylandto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other transplant surgery in Bethesda
- Chandra BhatiBaltimore$168K
- Robert MontgomeryBaltimore$159K
- Jonathan BrombergBaltimore$38K
- Jospeph ScaleaBaltimore$8K
- Russell WessonBaltimore$5K
- Raphael MeierBaltimore$5K
- Benjamin PhilosopheBaltimore$5K
- Saad MalikBaltimore$2K
- Daniel MalufBaltimore$2K
- Jordan PydaBaltimore$871
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.